{"interaction": {"mention_ids": ["72945835885"], "subtype": "link", "author": {"type": "user", "link": "http://www.facebook.com/profile.php?id=711501564", "avatar": "https://graph.facebook.com/711501564/picture", "name": "Jennifer Curran Miller-Smith", "id": "711501564"}, "created_at": "Thu, 30 Oct 2014 02:41:11 +0000", "title": "itsclinicaltrials.gov", "content": "The Isis SMN-Rx  infant (type 1) SMA study is now enrolling patients:\n\nNemours Children's Hospital\n\nOrlando, Florida, United States, 32827\n\nContact: Candace Eden MSN NE-BC LHRM, Clinical Research Nurse II\n\nNemours Research Institute\n\n6900 Lake Nona Blvd. 5th Floor\n\nOrlando, Florida  32827\n\n(w) 407-650-7216\n\n(fax) 407-650-7192\n\ncandace.eden@nemours.org\n\nor Dawn Cook, RN at dcook@nemours.org\n\nPrincipal Investigator: Richard Finkel, MD\n\n \n\nThe basic criteria for enrollment into this study are:\n\n\u00b7         Be 7 months (210 days) of age or younger at screening\n\nBe born (gestational age) between 37 and 42 weeksBe medically diagnosed with spinal muscular atrophy (SMA), with onset of features of SMA by 6 months of ageHave genetic confirmation of SMA and have a SMN2 Copy # of 2Body weight equal to or greater than 3rd percentile for ageReside within 9 hours ground travel each way, for the duration of the study\n\n\u00b7         Oxygen saturation awake and asleep  of 96%, without ventilation support during screening evaluation\n\nPlease refer to this study by itsClinicalTrials.gov identifier: NCT02193074 for further information.", "source": "Facebook for Android (350685531728)", "link": "http://www.facebook.com/72945835885_10152485648570886", "mentions": ["Cure SMA South Fl Chapter (formally FSMA)"], "received_at": 1414636895.1161, "media_type": "link", "type": "facebook", "id": "1e45fde35537ad80e0662612861106c0", "tags": ["tab7"], "schema": {"version": 3}}, "language": {"confidence": 99, "tag": "en", "tag_extended": "en"}, "links": {"url": ["http://itsclinicaltrials.gov/"], "created_at": ["Thu, 30 Oct 2014 02:41:35 +0000"], "code": [500], "normalized_url": ["http://itsclinicaltrials.gov"], "title": [""]}, "enrich": {"facebook": [{"username": "jennifer.curransmith", "first_name": "Jennifer", "last_name": "Curran Miller-Smith", "name": "Jennifer Curran Miller-Smith", "locale": "en_US", "gender": "female", "link": "https://www.facebook.com/jennifer.curransmith", "id": "711501564"}, {"description": "Cure SMA South Fl Chapter is here to provide patient and family support to those affected by Spinal Muscular Atrophy. We are raising community awareness and education. We raise funds to help find a treatment and ulitmately a cure. Contact Jennifer at 954-444-5937 ", "name": "Cure SMA South Fl Chapter (formally FSMA)", "privacy": "OPEN", "id": "72945835885", "venue": {"city": "Weston", "country": "United States", "longitude": -80.3882, "state": "Florida", "street": "", "latitude": 26.1075}, "updated_time": "2014-10-26T04:30:29+0000", "link": "www.curesma.org/SFlorida", "owner": {"id": "711501564", "name": "Jennifer Curran Miller-Smith"}, "email": "72945835885@groups.facebook.com", "icon": "https://fbstatic-a.akamaihd.net/rsrc.php/v2/y0/r/XCrOg4YmGg4.png"}]}, "demographic": {"gender": "female"}, "facebook": {"name": "itsclinicaltrials.gov", "caption": "itsClinicalTrials.gov", "created_at": "Thu, 30 Oct 2014 02:41:11 +0000", "author": {"type": "user", "link": "http://www.facebook.com/profile.php?id=711501564", "avatar": "https://graph.facebook.com/711501564/picture", "name": "Jennifer Curran Miller-Smith", "id": "711501564"}, "is_share": false, "application": "Facebook for Android", "link": "http://itsclinicaltrials.gov/", "source": "Facebook for Android (350685531728)", "message": "The Isis SMN-Rx  infant (type 1) SMA study is now enrolling patients:\n\nNemours Children's Hospital\n\nOrlando, Florida, United States, 32827\n\nContact: Candace Eden MSN NE-BC LHRM, Clinical Research Nurse II\n\nNemours Research Institute\n\n6900 Lake Nona Blvd. 5th Floor\n\nOrlando, Florida  32827\n\n(w) 407-650-7216\n\n(fax) 407-650-7192\n\ncandace.eden@nemours.org\n\nor Dawn Cook, RN at dcook@nemours.org\n\nPrincipal Investigator: Richard Finkel, MD\n\n \n\nThe basic criteria for enrollment into this study are:\n\n\u00b7         Be 7 months (210 days) of age or younger at screening\n\nBe born (gestational age) between 37 and 42 weeksBe medically diagnosed with spinal muscular atrophy (SMA), with onset of features of SMA by 6 months of ageHave genetic confirmation of SMA and have a SMN2 Copy # of 2Body weight equal to or greater than 3rd percentile for ageReside within 9 hours ground travel each way, for the duration of the study\n\n\u00b7         Oxygen saturation awake and asleep  of 96%, without ventilation support during screening evaluation\n\nPlease refer to this study by itsClinicalTrials.gov identifier: NCT02193074 for further information.", "type": "link", "id": "72945835885_10152485648570886", "to": {"ids": ["72945835885"], "names": ["Cure SMA South Fl Chapter (formally FSMA)"]}}, "salience": {"content": {"sentiment": 1}, "title": {"sentiment": 0}}}